Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Mexican Stock Exchange  >  Genomma Lab Internacional SAB de CV    LAB B   MX01LA010006

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mexican Stock Exchange
07/16/2018 07/17/2018 07/18/2018 07/19/2018 07/20/2018 Date
15.87(c) 16.04(c) 15.61(c) 15.29(c) 15.41 Last
3 953 859 4 814 938 3 940 647 3 849 915 4 860 042 Volume
-3.58% +1.07% -2.68% -2.05% +0.78% Change
More quotes
Financials (MXN)
Sales 2018 12 674 M
EBIT 2018 2 740 M
Net income 2018 1 630 M
Debt 2018 3 714 M
Yield 2018 -
Sales 2019 13 258 M
EBIT 2019 3 080 M
Net income 2019 1 710 M
Debt 2019 3 531 M
Yield 2019 2,84%
P/E ratio 2018 9,73
P/E ratio 2019 8,80
EV / Sales2018 1,56x
EV / Sales2019 1,47x
Capitalization 16 008 M
More Financials
Company
Genomma Lab Internacional SAB de CV engages in the development, manufacturing and marketing of pharmaceutical, beauty and personal care products.The company was founded on October 30, 1996 and is headquartered in México City, Mexico. 
Sector
Pharmaceuticals
Calendar
07/25Earnings Release
More about the company
Surperformance© ratings of Genomma Lab Internacional
Trading Rating : Investor Rating :
More Ratings
Latest news on GENOMMA LAB INTERNACIONAL
2013GENOMMA LAB INTERNACIONAL SAB DE CV : Anuncio Wal-mart - TCP
PU
2013GENOMMA LAB INTERNACIONAL SAB DE CV : quaterly earnings release
2013Mexico's Genomma Lab to Sell Products in U.S. Wal-Mart Stores
DJ
2012GENOMMA LAB INTERNACIONAL SAB DE CV : GLI Secures Committed Financing to acquire..
PU
2011GENOMMA LAB : Termination of XL-3 License Agreement
PU
More news
Sector news : Pharmaceuticals - NEC
07/20GLAXOSMITHKLINE : considers splitting up the group - FT
RE
07/20PFIZER : Biosimilar of Amgen's Neupogen Approved for Sale in the U.S.
DJ
07/20BAYER : to Stop Selling Essure in U.S.
DJ
07/20GLAXOSMITHKLINE : considers splitting up the group
RE
07/20GLAXOSMITHKLINE : Mulls Separation of Consumer Division -- FT
DJ
More sector news : Pharmaceuticals - NEC
Latest Tweets
2015Mexico's Genomma Lab sells stake in distributor unit for $88 mln  
More tweets
Qtime:37
News from SeekingAlpha
04/25Genomma Lab International SAB DE CV reports Q1 results 
2016THE DEUTSCHE X-TRACKERS MSCI MEXICO : A New World Leader? 
Chart GENOMMA LAB INTERNACIONAL
Duration : Period :
Genomma Lab Internacional  Technical Analysis Chart | LAB B | MX01LA010006 | 4-Traders
Technical analysis trends GENOMMA LAB INTERNACIONAL
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 14
Average target price 23,3  MXN
Spread / Average Target 51%
EPS Revisions
Managers
NameTitle
Máximo Juda Chief Executive Officer
Rodrigo Alonso Herrera Aspra Chairman
Antonio Zamora Galland Vice President-Administration & Finance
Juan Alonso Independent Director
Sabrina Lucila Herrera Aspra Director
Sector and Competitors
1st jan.Capitalization (M$)
GENOMMA LAB INTERNACIONAL SAB DE CV-25.49%842
JOHNSON & JOHNSON-9.93%337 790
PFIZER3.06%218 540
NOVARTIS-1.75%206 705
ROCHE HOLDING LTD.-5.90%200 737
MERCK AND COMPANY11.11%168 171